Arbutus Biopharma
ABUS
ABUS
48 hedge funds and large institutions have $115M invested in Arbutus Biopharma in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 8 closing their positions.
Holders
48
Holders Change
-3
Holders Change %
-5.88%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
5
Increased
17
Reduced
14
Closed
8
Calls
$880K
Puts
$819K
Net Calls
+$61K
Net Calls Change
+$151K
Top Buyers
1 |
QF
1
QVT Financial
New York
|
$55.1M |
2 |
AC
2
Armistice Capital
New York
|
$4.82M |
3 |
3
Bank of Montreal
Toronto,
Ontario, Canada
|
$2.96M |
4 |
KPF
4
K2 Principal Fund
Toronto,
Ontario, Canada
|
$370K |
5 |
5
Renaissance Technologies
New York
|
$399K |